Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)

CAPS Rating: 3 out of 5

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.

Results 1 - 20 of 35 : 1 2 Next »

Recs

0
Member Avatar wmansvelt (37.01) Submitted: 3/18/2014 3:40:04 PM : Underperform Start Price: $4.70 PGNX Score: -6.49

Although there is great potential and the profitability can change quickly the costs look excessive to say the least. I do note that there is no long term debt. this must indicate confidence of robust financial backers. i think there is a long way to go for the company

Recs

0
Member Avatar HIGHG33K (89.14) Submitted: 2/4/2014 12:21:59 AM : Outperform Start Price: $4.71 PGNX Score: -1.38

FDA will approve

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/4/2013 6:46:30 PM : Outperform Start Price: $3.95 PGNX Score: +20.82

Cow

Recs

0
Member Avatar genedom (97.85) Submitted: 9/9/2013 3:18:02 AM : Outperform Start Price: $5.90 PGNX Score: -29.63

Short term momentum

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/22/2013 4:56:09 PM : Underperform Start Price: $5.19 PGNX Score: +18.96

Short. Pharma. Revs down. Massive losses. Sells more stock than drugs.

Recs

0
Member Avatar scrubs62074 (79.35) Submitted: 2/20/2013 10:59:26 AM : Outperform Start Price: $2.90 PGNX Score: +51.75

Bullish MACD crossover on 02/20/13

Recs

0
Member Avatar MicroMagic (< 20) Submitted: 9/25/2012 11:51:15 PM : Underperform Start Price: $3.32 PGNX Score: -20.96

This company has a bright future with it's injectable drug to cure the terrible affliction many pain killer addicts have with constipation.

Since there is no known cure for constipation anywhere out there.

Recs

0
Member Avatar SamsaricSufferer (< 20) Submitted: 7/4/2012 8:14:51 PM : Outperform Start Price: $10.39 PGNX Score: -93.69

PDUFA coming up.

Recs

0
Member Avatar GameEmag (< 20) Submitted: 1/29/2012 5:26:11 PM : Underperform Start Price: $9.54 PGNX Score: +96.24

The recent jump in share price (Dec. '11-Current) has no basis in reality and seems fueled only by investors given to hoping for the best and low volume days allowing an easy path for pumping prices temporarily. To borrow words from so many market pundits it is the picture of "irrational exuberance."

Recs

0
Member Avatar 1stMartian (< 20) Submitted: 12/6/2011 11:26:56 PM : Underperform Start Price: $7.41 PGNX Score: +86.04

Piggy back off Z's analysis.

Recs

0
Member Avatar targetphil3 (< 20) Submitted: 10/1/2010 6:10:41 PM : Outperform Start Price: $5.05 PGNX Score: -68.66

CEO buying shares on regular basis

Recs

0
Member Avatar nhanhsong (< 20) Submitted: 6/23/2010 6:09:13 AM : Underperform Start Price: $5.62 PGNX Score: +86.65

If PGNX can't find a new partner for RELISTOR this year, it will face some difficulty with finance.

Recs

0
Member Avatar roalercoaster (30.19) Submitted: 3/29/2010 10:25:11 PM : Outperform Start Price: $5.22 PGNX Score: -67.51

Upcoming Catalyst

Recs

0
Member Avatar BeaterOfFools (< 20) Submitted: 3/13/2010 7:41:36 PM : Outperform Start Price: $5.28 PGNX Score: -71.86

Red Raider is Lord

Recs

0
Member Avatar FoolBeater (< 20) Submitted: 3/13/2010 7:24:08 PM : Outperform Start Price: $5.28 PGNX Score: -71.86

Lord knows

Recs

0
Member Avatar tdmitchell08 (< 20) Submitted: 2/9/2010 1:08:29 AM : Outperform Start Price: $4.52 PGNX Score: -68.14

I need help. I think this company will do well based on they look like they are at a low point, but will bounce back. If someone would like to let me know why I am right or wrong I would apprecaite it.

Recs

0
Member Avatar Contralogic (< 20) Submitted: 1/23/2010 10:11:50 AM : Outperform Start Price: $4.60 PGNX Score: -65.01

Go Bio!

Recs

0
Member Avatar biofest (42.51) Submitted: 12/6/2009 3:19:13 PM : Outperform Start Price: $4.14 PGNX Score: -51.20

Speculative but possible cancer effect from pain drug.

Recs

0
Member Avatar Baski101 (< 20) Submitted: 11/17/2009 9:17:29 AM : Outperform Start Price: $4.17 PGNX Score: -52.09

Its basically cash rich, has a few good products waiting to be launched once a partner is found for marketing, and its current stock price is an all time low, which can't get any worse than this.

Recs

0
Member Avatar moko1987 (< 20) Submitted: 9/16/2009 1:53:44 AM : Outperform Start Price: $5.36 PGNX Score: -89.02

Great

Results 1 - 20 of 35 : 1 2 Next »

Featured Broker Partners


Advertisement